semaglutide heart Long-Term SELECT Trial: Cuts Cardiovascular Events by 20% beyond Weight Loss Real-world data link semaglutide, tirzepatide
Description
The mechanism is well understood and supported by scientific literature: 1

GIP receptor activation improves insulin sensitivity through pathways independent of GLP-1

But while these GLP-1 drugs for diabetes and weight loss may no longer be in shortage in the U.S., there are many countries around the world that cannot access them

Importantly, individuals retain their own lawyers, have their own rights of recovery and have their own burden of proof

Meanwhile, derm-loved brand Skinbetter Science published an explainer on its site detailing how several of its products, including the InterFuse Treatment Cream, may benefit GLP-1 users by supporting density and barrier function

Results showed that after 72 weeks, participants on tirzepatide experienced significant weight loss: 15.0% with 5 mg, 19.5% with 10 mg, and 20.9% with 15 mg, compared to a 3.1% weight loss with the placebo
